Seung-uon Shin

发表

Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell-dependent cytotoxicity.

I. Lossos, J. Timmerman, J. Rosenblatt, 2017, Blood.

Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction

H. Federoff, D. Morgensztern, H. Nechushtan, 2008, Cancer Immunology, Immunotherapy.

Antisense Drug Delivery to the Brain Targeting : Initial Applications in Anti-HIV Delivery Vehicle for Effective Brain for the Transferrin Receptor Serves as a An Antibody-Avidin Fusion Protein Specific Pardridge

S. Morrison, M. Penichet, W. Pardridge, 1999 .

Genetically engineered antibodies and their application to brain delivery.

S. Morrison, Seung-uon Shin, Seung-Uon Shin, 1995, Advanced drug delivery reviews.

Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases

S. Carroll, S. Ramakrishnan, J. Rosenblatt, 2021, Cells.

Breast Cancer Therapy Using Antibody-Endostatin Fusion Proteins

Seung-uon Shin, Seung-Uon Shin, 2008 .

Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her‐2/neu antigen

Yeonseok Chung, Hyun-Mi Cho, Seung-uon Shin, 2002, International journal of cancer.

B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion

E. Podack, J. Rosenblatt, T. Schreiber, 2012, Cancer Immunology, Immunotherapy.

Potential role of chemokines in immune therapy of cancer.

J. Rosenblatt, K. Tolba, Seung-uon Shin, 2002, The Israel Medical Association journal : IMAJ.

Comparison of the antitumor efficacies of Her-2/neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in mice.

Yeonseok Chung, Seung-uon Shin, C. Kang, 2003, Vaccine.

T Cell Costimulatory Pathway Antibody Specificity and Ability to Activate Via A B 7 . 1-Antibody Fusion Protein

S. Morrison, M. Penichet, D. Slamon, 1998 .

Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses.

R. Morgan, E. Clark, W. Khan, 2016, International immunology.

Lipid Binding Peptides Region of Surface and Core Fraction from Apo B-100 of Human LDL

Y. Jang, K. Hwang, Hyun-Mi Cho, 2022 .

Production of Genetically Engineered Antibodies in Myeloma Cells: Design, Expression, and Applications

A. Wright, Seung-uon Shin, 1991 .

Chimeric antibody: Potential applications for drug delivery and immunotherapy

Seung-uon Shin, Seung-Uon Shin, 1991, Biotherapy.

Instability of immunoglobulin genes in S107 cell line

D. Zack, R. DePinho, S. Rudikoff, 1991, Somatic cell and molecular genetics.

An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells

S. Morrison, M. Penichet, D. Shin, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein

S. Morrison, M. Penichet, K. Webster, 2005, Molecular Cancer Therapeutics.

Antibodies and antibody-fusion proteins as anti-angiogenic, anti-tumor agents

K. Webster, C. Calfa, J. Rosenblatt, 2006 .

Targeted Delivery of an Antibody–Mutant Human Endostatin Fusion Protein Results in Enhanced Antitumor Efficacy

J. Merchan, S. Ramakrishnan, J. Rosenblatt, 2011, Molecular Cancer Therapeutics.

Increased rejection of primary tumors in mice lacking B cells: Inhibition of anti‐tumor CTL and TH1 cytokine responses by B cells

A. Divekar, B. Segal, J. Rosenblatt, 2005, International journal of cancer.

Studies on the Somatic Instability of Immunoglobulin Genes in vivo and in Cultured Cells

R. DePinho, H. Aguila, D. French, 1987, Immunological reviews.

Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response.

C. Calfa, D. Shin, J. Rosenblatt, 2009, Cancer research.

Microenvironment and Immunology Delivery of NKG 2 D Ligand Using an Anti-HER 2 Antibody-NKG 2 D Ligand Fusion Protein Results in an Enhanced Innate and Adaptive Antitumor Response

C. Calfa, D. Shin, J. Rosenblatt, 2010 .

Model for in vivo progression of tumors based on co-evolving cell population and vasculature

Neil F. Johnson, Guannan Zhao, Zhenyuan Zhao, 2011, Scientific reports.

An antibody-avidin fusion protein specific for the transferrin receptor serves as a delivery vehicle for effective brain targeting: initial applications in anti-HIV antisense drug delivery to the brain.

S. Morrison, M. Penichet, W. Pardridge, 1999, Journal of immunology.

Targeted Delivery of an Antibody–Mutant Human Endostatin Fusion Protein Results in Enhanced Antitumor Efficacy

J. Merchan, S. Ramakrishnan, J. Rosenblatt, 2011, Molecular Cancer Therapeutics.